AtaiBeckley awarded ‘Buy' rating in initial coverage from Deutsche Bank analysts

Deutsche Bank has initiated coverage on AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) assigning a 'Buy' rating and setting a price target of $12, implying potential upside of around 320% from current levels. In a note to clients, analysts highlighted the company's position in the emerging field of psychedelic medicine for mental health.